Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score

Research output: Contribution to journalJournal articleResearchpeer-review

  • Amanda Mocroft
  • Bruno Ledergerber
  • Kai Zilmer
  • Kirk, Ole
  • Bernard Hirschel
  • Jean-Paul Viard
  • Peter Reiss
  • Patrick Francioli
  • Adriano Lazzarin
  • Ladislav Machala
  • Andrew N Phillips
  • Lundgren, Jens
  • EuroSIDA study group and the Swiss HIV Cohort Study
To derive and validate a clinically applicable prognostic score for predicting short-term disease progression in HIV-infected patients taking combination antiretroviral therapy (cART).
Original languageEnglish
Issue number14
Pages (from-to)1867-1875
Number of pages9
Publication statusPublished - 2007

    Research areas

  • Acquired Immunodeficiency Syndrome, Adult, Anemia, Anti-Retroviral Agents, Body Mass Index, CD4 Lymphocyte Count, Disease Progression, Drug Therapy, Combination, Female, HIV Infections, HIV Seropositivity, HIV-1, Humans, Male, Prognosis, Prospective Studies, Reproducibility of Results, Risk Assessment, Viral Load

ID: 4039747